NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Accumulated Expenses (2016 - 2026)

NextPlat's (NXPL) quarterly Accumulated Expenses came in at $1.8 million in Q2 2026, up 741.35% year-over-year from $208000.0 in Q2 2025, and little changed quarter-over-quarter from $1.8 million in Q4 2025.

Analysis

NextPlat (NXPL) Accumulated Expenses (2016 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Accumulated Expenses for 10 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Accumulated Expenses rose 741.35% year-over-year to $1.8 million in Q2 2026; TTM through Jun 2026 was $1.8 million, a 741.35% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 550.56% from the prior year.
  • Accumulated Expenses was $1.8 million for Q2 2026 at NextPlat, roughly flat from $1.8 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $1.8 million in Q4 2025 and troughed at $17389.0 in Q2 2022.
  • A 5-year average of $383293.2 and a median of $208000.0 in 2025 frame the typical range for Accumulated Expenses.
  • The widest YoY moves for Accumulated Expenses: up 16515.94% in 2022, down 85.69% in 2022.
  • Over 5 years, Accumulated Expenses stood at $23000.0 in 2022, then surged by 769.57% to $200000.0 in 2023, then jumped by 34.5% to $269000.0 in 2024, then surged by 550.56% to $1.8 million in 2025, then changed by 0.0% to $1.8 million in 2026.
  • The last three Accumulated Expenses figures came in at $1.8 million (Q2 2026), $1.8 million (Q4 2025), and $378000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.75 Mn
Dec 31, 2025 1.75 Mn
Sep 30, 2025 378,000.00
Jun 30, 2025 208,000.00
Mar 31, 2025 402,000.00
Dec 31, 2024 269,000.00
Sep 30, 2024 449,000.00
Jun 30, 2024 199,000.00
Mar 31, 2024 378,000.00
Dec 31, 2023 200,000.00
Sep 30, 2023 366,569.00
Jun 30, 2023 30,914.00
Mar 31, 2023 27,835.00
Dec 31, 2022 23,000.00
Sep 30, 2022 22,930.00
Jun 30, 2022 17,389.00
Mar 31, 2022 44,347.00
Dec 31, 2021 20,107.00
Sep 30, 2021 138.00
Jun 30, 2021 121,476.00